In this article
Proximity labeling is a lab method that tags nearby molecules to reveal what is surrounding a target protein inside a cell. Think of it like putting sticky notes on everyone who stands near a specific person at a party. TurboID is a popular enzyme (a protein that speeds up chemical reactions) used for this. It attaches a small chemical marker called biotin to any nearby protein. But what about small molecules? That area of research has barely been explored, until now.
A team led by researchers at Seoul National University has developed DESTNI (desthiobiotin ligase). This engineered enzyme (one carefully built and improved in the lab) does for metabolites (the small molecules cells make and use for energy and other tasks) what TurboID does for proteins.
Their method, published as a preprint on bioRxiv, can identify amine-containing metabolites (small molecules that carry a chemical group called an amine) in specific locations inside living cells. For researchers working with peptides (short chains of amino acids used in lab studies), this is more than just another method paper. It opens a window into the biochemical environment that your compounds actually interact with at the bench.
What DESTNI Actually Does
DESTNI is built from TurboID using a process called directed evolution. Directed evolution is like selective breeding for enzymes. Scientists make many random changes to an enzyme, keep the versions that work best, and repeat the process many times. The team used a yeast display system (a method that uses yeast cells to test thousands of enzyme versions at once) to find the best candidates. The goal was an enzyme that could efficiently attach desthiobiotin (DTB), a close chemical cousin of biotin, to amine-containing metabolites.
The Advantage of Desthiobiotin
Why use desthiobiotin instead of biotin? DTB gives cleaner enrichment. That means it pulls out more of the molecules you actually want, with less unwanted background noise, especially in mass spectrometry (MS) workflows. Mass spectrometry is a lab technique that identifies molecules by measuring their mass. The key advance is that DESTNI does not just tag any molecule floating nearby. It labels metabolites in a compartment-specific manner, meaning it only tags molecules inside the specific cell compartment (a distinct section inside a cell, like a room in a building) where it has been placed.
The team tested specially built versions of DESTNI aimed at different compartments, including the mitochondrial matrix (the innermost section of the cell's energy-producing structure) and the nucleus (the compartment that holds the cell's genetic material). Each targeted version consistently pulled out a distinct set of metabolites from that compartment. This shows the enzyme was labeling molecules right where it was placed, not drifting into other areas.

What They Found
When they aimed DESTNI at the mitochondrial matrix (the innermost compartment of the mitochondria, often called the cell's power plant), it pulled out a distinct set of metabolites, including:
- Glycine
- 5-aminolevulinic acid
- Ornithine
- Spermidine adducts
These findings make sense. The mitochondrial matrix is where cells build heme (the molecule that carries oxygen in red blood cells) and process urea cycle intermediates (byproducts created when the body breaks down proteins). All of the metabolites found fit that environment well.
When DESTNI was aimed at the nucleus, it recovered a completely different set of molecules, including:
- γ-aminobutyric acid (GABA)
- 5-aminovaleric acid adducts
These findings also fit. GABA plays a role in chromatin regulation (the process of controlling how tightly DNA is packed, which affects which genes are active). The nucleus is also known to be rich in enzymes that handle amine-containing molecules.
An Integrated Analytical Framework
Identifying molecules tagged with DTB is not simple. The DTB tag changes the way molecules break apart inside the mass spectrometer, making them harder to recognize. To solve this, the team built an integrated analytical framework (a full, step-by-step system for identifying labeled molecules) that combines:
- DTB-modified metabolite standards (known reference samples with the DTB tag already attached, used for comparison)
- In vitro profiling (testing the enzyme's labeling in a controlled lab setting, outside of living cells)
- Machine learning MS/MS prediction (using computer software trained on large datasets to predict how tagged molecules will break apart in the mass spectrometer)
This combined approach gives researchers a reliable way to identify exactly what is being labeled.

Why This Matters for Peptide Work
Here is where this connects to bench work: peptide stability and degradation (how well a peptide holds together or how quickly it breaks down) do not happen in an empty space. They are shaped by the local metabolite environment, including the amines, buffers, and reactive molecules surrounding your reconstituted compound (a compound you have dissolved and prepared for use in a vial).
Knowing which metabolites are concentrated in specific compartments gives a clearer picture of what a peptide might encounter in a cell system. Glycine and ornithine in the mitochondria, or GABA in the nucleus, are not random. They form the biochemical backdrop that your compound enters when you work with cell-based samples.
Applications in Peptide Uptake and Trafficking
More practically, if you are studying how a peptide is taken up by cells, how it moves through the cell interior (intracellular trafficking), or how it acts in specific compartments, DESTNI-style proximity labeling gives you a direct readout of the metabolite landscape in those compartments. That helps you understand what is happening to your compound at a step-by-step chemical level.
The method also opens the door for studying how peptides and metabolites interact right inside living cells. Traditional approaches look at metabolites or proteins in isolation, separated from the cell. DESTNI lets you see them in the context of actual living cell structure. For researchers working with peptide-drug conjugates (peptides chemically linked to drug molecules) or studying how peptides affect metabolic pathways, this spatial resolution (the ability to pinpoint exactly where things are happening) matters.
The Practical Angle
If you are reconstituting peptides (dissolving dried peptide powder in a liquid for cell culture experiments), you are already thinking about buffer composition, pH, and storage temperature. DESTNI research is a reminder that the environment inside the cell is equally complex, and increasingly something we can map and understand.
The method is not yet available as a commercial kit, but the enzyme engineering principles here follow the same path that made TurboID widely used. Once the directed evolution work is finished, the tool becomes broadly available to other labs. The preprint provides enough detail for labs with protein expression capacity (the equipment and know-how to produce proteins from scratch) to explore similar strategies.
Key point: DESTNI expands proximity labeling from proteins to metabolites, enabling researchers to map the precise small-molecule environments where peptides and other compounds interact inside living cells.
The broader takeaway is this: spatial metabolomics (the study of where small molecules are located inside cells) is catching up to spatial proteomics (the same idea applied to proteins). The same proximity labeling logic that mapped protein neighborhoods can now map small-molecule neighborhoods. We are entering an era where we can see not just where proteins go, but what biochemical environment they actually live in.
For peptide researchers, that is a meaningful shift. Your compounds do not act in isolation. They act in metabolically active environments shaped by local concentrations of amines, amino acids, and reactive molecules. DESTNI and tools like it give us ways to map those environments directly.
Prompted by this coverage at bioRxiv →
Related from our lab: the pen · cartridges · bacteriostatic water · peptide calculator
Shared by Preppin Peppers for research, educational, and demonstration awareness only. We link to third-party coverage; we do not endorse it, and nothing here is medical advice or a recommendation to use any substance in humans or animals. Our products are sold for laboratory research use only.
Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.
Frequently asked questions
What is DESTNI and how does it differ from TurboID for metabolite labeling?
DESTNI is an engineered enzyme derived from TurboID that tags amine-containing metabolites with desthiobiotin, whereas TurboID only tags proteins. It enables small molecule mapping in living cells.
How does compartment-specific metabolite labeling work in cells?
DESTNI labels metabolites only in the specific cell compartment where it's expressed (e.g., mitochondria or nucleus), allowing researchers to identify which metabolites are present in each cellular region without contamination from other areas.
What are the advantages of using desthiobiotin over biotin in proximity labeling?
Desthiobiotin provides cleaner enrichment in mass spectrometry workflows because it binds less nonspecifically to proteins, reducing background noise and improving detection of the tagged metabolites compared to biotin.
What the research community gets wrong about DESTNI and desthiobiotin metabolite labeling
- Treating it like a product you can order. DESTNI is described in a preprint, not a finished commercial kit. The directed evolution work is still in progress, so labs that want to try it need to express the enzyme themselves rather than buy it off a shelf.
- Assuming desthiobiotin (DTB) is just a swap for biotin. The point of DTB is that it binds streptavidin reversibly, so tagged material can be released with a gentle biotin competition step instead of harsh denaturing conditions. That is the whole reason to use it, not a minor detail.
- Thinking it tags proteins like TurboID. TurboID labels nearby proteins. DESTNI is engineered to tag small amine-containing metabolites. Different target class, so do not expect a protein interaction map from it.
- Reading a label as proof a molecule lives in that compartment. A signal shows what the enzyme could reach and tag where it was placed. Confirming identity still needs DTB-tagged reference standards and MS/MS prediction, not the enrichment step alone.
- Expecting the DTB tag to make mass spec easier. The tag actually changes how molecules break apart in the instrument, which makes them harder to recognize. That is why the reported workflow leans on standards and computational prediction.
From our bench: If you run desthiobiotin-tagged samples over streptavidin beads, we would like to log real numbers on the gentle elution step. Tell us the recovery you measure when you release material with a biotin competition buffer under native conditions versus a harsh denaturing elution, along with the buffer, bead lot, and readout you used. We will not publish any figure we have not received from an actual run at your bench.
Sources
- Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
- Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
- Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
- Branon et al., Nat Biotechnol 2018 , Efficient proximity labeling in living cells and organisms with TurboID (biotin ligase engineered by directed evolution)
- PubChem , Desthiobiotin (CID 445027, C10H18N2O3)
- Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins, J Vis Exp 2018 (reversible binding, gentle biotin-competition elution)
✔ Reviewed by Bryan Le, PharmD, RPh
Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.